Acute pain, analgesia and sedation in children (IIIa): Pharmacokinetics and pharmacodinamics of sedantives;Dolor agudo, analgesia y sedacion en el nino (IIIb): Farmacocinetica y farmacodinamia de los sedantes

Anales Espanoles de Pediatria

Volumn 48, Issue 5, 1998, Pages 541-548

  Valdivielso Serna, A ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CHLORAL HYDRATE; CLORAZEPATE; DROPERIDOL; FLUMAZENIL; HALOPERIDOL; LORAZEPAM; MIDAZOLAM; PENTOBARBITAL; PHENOTHIAZINE DERIVATIVE; PROPOFOL; SEDATIVE AGENT; HYPNOTIC SEDATIVE AGENT;

ANALGESIA; ARTICLE; DRUG ELIMINATION; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; HUMAN; LIVER TOXICITY; NEPHROTOXICITY; PAIN; SEDATION; ACUTE DISEASE; CHILD; CONSCIOUS SEDATION; REVIEW;

ACUTE DISEASE; ANALGESIA; BENZODIAZEPINES; CHILD; CONSCIOUS SEDATION; HUMANS; HYPNOTICS AND SEDATIVES; PAIN; PROPOFOL;

EID: 7144254445     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Study R y Barker J: Cellular mechanisms of benzodiacepine action. JAMA 1982;247:2147-2152.
2. Shader RJ y Greebblatt DJ: Use of benzodiacepines in anxiety disorders. N Eng J Med 1993; 328:1398-1405.
3. Bergman Y, Steeves M, Burckart G et al: Reversible neurologic abnormalities associated with prolongued intravenous midazolam and fentanyl administration. J Pediatr 1991; 119:644-649.
4. Shelly M, Sultan M, Bodenham A et al: Midazolam infusions in critically ill patients. Eur J Anaestesiol 1991;8:21-25.
5. Amrein R, Hetzel W. Pharmacology of drugs frequently used in ICUs: midazolam and flumazenil. Intensive Care Med 1991; 17:S9-S18.
6. Chamorro C, Romera MA, Estecha MA y Rubio JJ. Sedación en cuidados intensivos. Nuevos fármacos para nuevas tendencias. Med Intens 1994;18:164-172.
7. Rosen D y Rosen K: Midazolam for sedation in the pediatric intensive care unit. Int Care Med 1991; 17:S15-19.
8. Payne K, Mattheyse FJ, Liebenberg et al: The pharmacokinetics of midazolam in paediatric patients. Eur J Clin Pharmacol 1989; 37:267-272.
9. Rodriguez A, Martinon JM, Rivas P et al: Valoración de la utilidad de una nueva benzodicepina en la sedación de niños. Rev Esp Pediatr 1991; 47:228-232.
10. Valdivielso Serna A: Analgesia y sedación: Analgesia para procedimientos y Analgesia Controlada por el Paciente. En: Niño Criticamente Enfermo. Casado J y Serrano A. Eds. Diaz de Santos SA. Madrid. 1996:265-281.
11. McDonald CF, Thompsom SA, Scott NC et al: Benzodiazepine-opiate antagonism. A problem in intensive care therapy. Intens Care Med 1986; 12:39-42.
12. Yaster M y Coté C: Sedatives hypnoptics, anxiolytics and amnesties. En: Yaster M, Krane E, Kaplan R, Coté C y Lappe D Eds. Pédiatric pain management and sedation hand-book. Mosby-Year Book Inc. St Louis. 1997:29-49.
13. Breheny FX, Bao BCH. Reversal of midazolam sedation with flumazenil. Crit Care Med 1992; 20:736-839.
14. Bodenham A, Brownlie G, Dixon J et al: Reversal of sedation by prolonged infusion of flumazenil. Anesthesia 1988; 43:376-380.
15. Lopez-Herce J, Lopez de Sa E y Garcia de Frias E. Reversal midazolam sedation with rectal flumazenil in children. Crit Care Med 1994; 22:1204.
16. Fisher DM. Propofol in pediatrics. Anesthesiology 1994; 80:2-5.
17. Hannallah R, Baker S, Casey W y cols. Propofol: Efective dose and induction characteristics in unpremedicated children. Anesthesiology 1991; 74:217-219.
18. Kataria BK, Ved SA, Nicodemus HF y cols: The pharmacokinetics of propofol in children using three different data analysis approaches. Anessthesiology 1994; 80:104-122.
19. Reed MD, Yamashita TS. Marx CM y cols: A pharmacokinetically based propofol dosing strategy for sedation of the critically ill, mechanically ventilated pediatric patient. Crit Care Med 1996; 24:1473-1481.
20. Marx CM, Lebovitz DL, Blumer JL y cols: Preliminary evaluation of propofol monotherapy for sedation of mechanically ventilated children. Abstr. Clin Pharmacol Ther 1993; 53:143.
21. Smith Y, White P, Nathanson M et al: Propofol: An update on its clinical use. Anesthesiology 1994; 81:1005-1043.
22. Borgeat A, Wilder-Smith and Suter PM. The nonhypnotic therapeutic applications of propofol. Anesthesiology 1994; 80:642-656.
23. Imray J, Hay A: Withdrawal syndrome after propofol. Anaesthesia 1991; 46:704.
24. Pirttikangas CO, Perttilä J y Salo M. Propofol emulsion reduces proliferative responses of limphocytes from intensive care patients. Intensive Care Med: 1993; 19:299-302.
25. Parke TJ, Stevens JE, Rice ASC y cols. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ, 1992; 305:613-616.
26. Strickland RA y Murray MJ. Fatal metabolic acidosis in a pediatric patient receiving an infusion of propofol in the intensive care unit: Is there a relation ship?. Crit Care Med 1995; 23:405-409.
27. Cook S. Propofol infusion in children. BMJ 1992; 305:952-954.
28. U.S. Food an Drug Administration's Center for Drug Evaluation and Research. Report of Anesthetic and Life Support Drugs Advisor Committee Meeting. Rockville, MD, November 23, 1992. Reprints available from N R Gross, 1323 Rhode Island Av. NW, Washington, DC 20005.
29. Meakin G: Role of propofol in pediatric anaesthetic practice. Pediatr Anaesth 1995; 5:147-149.
30. Hatch DJ: Propofol in paediatric intensive care. Br J Anaesth 1997; 79:274-275.
31. Anderson C, Zeltzer L, Fanurick D: Procedural pain En: Pain in infants, childrens and adolescents. Schechter NL, Berde CB and Yaster M. (Eds) Williams & Wilkins. Baltimore. 1993;435-458.
32. Mirski MA, Muffelman B, Ulatowski JA y Hasnley DF: Sedation for the critically ill neurologic patient. Crit Care Med 1995;23:2038-2053.
33. Mayers DJ: Clhoral hydrate disposition following single-dose administration to critically ill neonates and chidren. Develop Pharmacol Therap 1991; 16:71-77.
34. Zeltzer L, Jay S, Fisher D: Tratamiento del dolor relacionado con procedimientos pediátricos. Clin Pediatr N Am (Ed Española) 1989; 4:1023-1049.
35. Roberts JR: Miscellaneous drugs: Narcotic analgesics; sedatives and hypnoptics; local anesthetics. En: Roberts JR de. Drug Therapy in infants: Pharmacologic principles an clinical experience. WB Saunders Company 1984:301-308.
36. Settle E y Ayd F: Haloperidol: A quarter century of experience. J Clin Psyquiatry 1983; 44: 440-448.
37. Tesar G, Murray G, Cassem N: Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients. J Clin Psychopharmacol 1985;5:344349.
38. Michenfelder JD, Theye RA; Effects of fentalnyl, droperidol, and innovar on canine cerebral metabolism and blood flow. Br J Anaesth 1971; 43:630-635.
39. Magliozzi J, Gillespie H, Lombrozo L et al: Mood alteration following oral an intravenous halopendol and relationship to drug concentration in normal subjects. J Clin Pharmacol 1985;25:285-288.
40. Castañeda Casado FJ. Anestésicos generales o hipnópticos utilizables en sedación. En: Castañeda Casado FJ Ed. Sedación y analgesia en el paciente grave. Erika Medica. Barcelona. 1994; pags: 57-72.
41. Crippen D: The role of sedation in the ICU patient with pain and agitation. Crit Care Clin 1990; 6:369-392.